Your browser doesn't support javascript.
loading
PML risk stratification using anti-JCV antibody index and L-selectin.
Schwab, Nicholas; Schneider-Hohendorf, Tilman; Pignolet, Béatrice; Spadaro, Michela; Görlich, Dennis; Meinl, Ingrid; Windhagen, Susanne; Tackenberg, Björn; Breuer, Johanna; Cantó, Ester; Kümpfel, Tania; Hohlfeld, Reinhard; Siffrin, Volker; Luessi, Felix; Posevitz-Fejfár, Anita; Montalban, Xavier; Meuth, Sven G; Zipp, Frauke; Gold, Ralf; Du Pasquier, Renaud A; Kleinschnitz, Christoph; Jacobi, Annett; Comabella, Manuel; Bertolotto, Antonio; Brassat, David; Wiendl, Heinz.
Afiliação
  • Schwab N; Department of Neurology, University of Münster, Germany nicholas.schwab@ukmuenster.de heinz.wiendl@ukmuenster.de.
  • Schneider-Hohendorf T; Department of Neurology, University of Münster, Germany.
  • Pignolet B; Pole des Neurosciences Centre Hospitalier Universitaire Toulouse, CPTP INSERM UMR 1043 et Université de Toulouse, UPS, France.
  • Spadaro M; Clinical Neurobiology Unit, Regional Referring Multiple Sclerosis Centre (CRESM), Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Orbassano, Italy.
  • Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Germany.
  • Meinl I; Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University Munich and Munich Cluster Systems Neurology (SyNergy), Germany.
  • Windhagen S; Department of Neurology, Clinics Osnabrück, Germany.
  • Tackenberg B; Department of Neurology, Philipps University and University Clinics Gießen and Marburg, Germany.
  • Breuer J; Department of Neurology, University of Münster, Germany.
  • Cantó E; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
  • Kümpfel T; Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University Munich and Munich Cluster Systems Neurology (SyNergy), Germany.
  • Hohlfeld R; Institute for Clinical Neuroimmunology, Ludwig-Maximilians-University Munich and Munich Cluster Systems Neurology (SyNergy), Germany.
  • Siffrin V; Department of Neurology, University of Mainz, Germany.
  • Luessi F; Department of Neurology, University of Mainz, Germany.
  • Posevitz-Fejfár A; Department of Neurology, University of Münster, Germany.
  • Montalban X; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
  • Meuth SG; Department of Neurology, University of Münster, Germany.
  • Zipp F; Department of Neurology, University of Mainz, Germany.
  • Gold R; Department of Neurology, Ruhr University Bochum, Germany.
  • Du Pasquier RA; Divisions of Immunology and Allergy and of Neurology, Centre Hospitalier Universitaire Vaudois, Switzerland.
  • Kleinschnitz C; Department of Neurology, University of Würzburg, Germany.
  • Jacobi A; Division of Rheumatology and Clinical Immunology, University of Münster, Germany/Division of Rheumatology and Clinical Immunology, Brandenburg Medical School, Neuruppin, Germany.
  • Comabella M; Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain.
  • Bertolotto A; Clinical Neurobiology Unit, Regional Referring Multiple Sclerosis Centre (CRESM), Neuroscience Institute Cavalieri Ottolenghi (NICO), University Hospital San Luigi Gonzaga, Orbassano, Italy.
  • Brassat D; Pole des Neurosciences Centre Hospitalier Universitaire Toulouse, CPTP INSERM UMR 1043 et Université de Toulouse, UPS, France/David Brassat also represents the BioNAT study group.
  • Wiendl H; Department of Neurology, University of Münster, Germany.
Mult Scler ; 22(8): 1048-60, 2016 07.
Article em En | MEDLINE | ID: mdl-26432858
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Oportunistas / Leucoencefalopatia Multifocal Progressiva / Vírus JC / Selectina L / Natalizumab / Anticorpos Antivirais / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Oportunistas / Leucoencefalopatia Multifocal Progressiva / Vírus JC / Selectina L / Natalizumab / Anticorpos Antivirais / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article